June 08, 2025 a 09:31 am

Healthcare Stocks - Performance Analysis

Healthcare Stocks Analysis

๐Ÿ“Š The healthcare sector showed varied performance across different time frames. Recent volatilities indicate a mix of both growth opportunities and cautionary tales, especially with big names in the sector. This analysis delves into the short-term and longer-term performances to identify key trends and potential investment opportunities. Let's dive into the data.

Healthcare Stocks Performance One Week

๐Ÿ“ˆ Over the last week, Eli Lilly (LLY) emerged as the top performer with a significant rise, contrasting with Thermo Fisher Scientific (TMO) which posted losses. Overall, the sector experienced mixed results with moderate growth seen in several stocks.

Stock Performance (%) Performance
LLY 4.31
MRK 2.77
ABBV 1.99
ISRG 0.86
AMGN 0.76
UNH 0.48
ABT 0.00
JNJ -0.11
TMO -0.20
One Week Performance Chart

Healthcare Stocks Performance One Month

๐Ÿ“Š The last month saw substantial volatility, with Amgen (AMGN) leading with a strong positive performance, whereas UNH experienced significant losses. This variance highlights the differing market sentiments and external pressures on individual stocks.

Stock Performance (%) Performance
AMGN 9.11
LLY 5.06
MRK 4.37
ISRG 3.91
ABBV 3.09
JNJ 0.66
ABT 0.41
TMO 0.26
UNH -19.51
One Month Performance Chart

Healthcare Stocks Performance Three Months

๐Ÿ“‰ The three-month overview reflects a broader decline across the sector, with ISRG being the standout positive performer. The overall trend underscores a need for cautious analysis amid prevailing market headwinds.

Stock Performance (%) Performance
ISRG 16.69
ABBV -11.83
AMGN -10.87
LLY -4.14
ABT -2.08
JNJ -7.08
MRK -17.24
TMO -25.13
UNH -38.94
Three Month Performance Chart

Summary

๐Ÿ’ก Across the review periods, significant discrepancies in stock performances were evident. While some stocks like ISRG and LLY showed resilience and growth, others such as UNH and TMO faced substantial declines. Investors should consider macroeconomic factors and company-specific news that could impact future trajectories. Diversification and thorough analysis remain key in navigating healthcare market investments.